Global Digiceutical 麻豆原创 Research Report 2023

Publication ID:

PB504233126

Publication Date:

April 4, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The digiceuticals market is anticipated to be driven by rising smartphone prevalence in developed and emerging nations, the affordability of digital healthcare technology for both consumers and providers, and a rising desire for integrated health systems and patient-centered treatment
The global Digiceutical market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Digiceutical is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Digiceutical is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Digiceutical in Smartphone is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Digiceutical include Pear Therapeutics Inc, Akili Interactive Labs, Inc, Propeller Health, Welldoc, Voluntis and Chrono Therapeutics Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Digiceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digiceutical.
The Digiceutical market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Digiceutical market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Digiceutical companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Pear Therapeutics Inc
Akili Interactive Labs, Inc
Propeller Health
Welldoc
Voluntis
Chrono Therapeutics Inc.
Segment by Type
Diabetes Management
Substance Abuse
Pulmonary Diseases
Alcohol and Smoking Addiction
Neurological Disorders
Segment by Application
Smartphone
Watches
Medical Device System
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Digiceutical companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Digiceutical 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Diabetes Management
1.2.3 Substance Abuse
1.2.4 Pulmonary Diseases
1.2.5 Alcohol and Smoking Addiction
1.2.6 Neurological Disorders
1.3 麻豆原创 by Application
1.3.1 Global Digiceutical 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Smartphone
1.3.3 Watches
1.3.4 Medical Device System
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Digiceutical 麻豆原创 Perspective (2018-2029)
2.2 Digiceutical Growth Trends by Region
2.2.1 Global Digiceutical 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Digiceutical Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Digiceutical Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Digiceutical 麻豆原创 Dynamics
2.3.1 Digiceutical Industry Trends
2.3.2 Digiceutical 麻豆原创 Drivers
2.3.3 Digiceutical 麻豆原创 Challenges
2.3.4 Digiceutical 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Digiceutical Players by Revenue
3.1.1 Global Top Digiceutical Players by Revenue (2018-2023)
3.1.2 Global Digiceutical Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Digiceutical 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Digiceutical Revenue
3.4 Global Digiceutical 麻豆原创 Concentration Ratio
3.4.1 Global Digiceutical 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digiceutical Revenue in 2022
3.5 Digiceutical Key Players Head office and Area Served
3.6 Key Players Digiceutical Product Solution and Service
3.7 Date of Enter into Digiceutical 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Digiceutical Breakdown Data by Type
4.1 Global Digiceutical Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Digiceutical Forecasted 麻豆原创 Size by Type (2024-2029)
5 Digiceutical Breakdown Data by Application
5.1 Global Digiceutical Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Digiceutical Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Digiceutical 麻豆原创 Size (2018-2029)
6.2 North America Digiceutical 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Digiceutical 麻豆原创 Size by Country (2018-2023)
6.4 North America Digiceutical 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Digiceutical 麻豆原创 Size (2018-2029)
7.2 Europe Digiceutical 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Digiceutical 麻豆原创 Size by Country (2018-2023)
7.4 Europe Digiceutical 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Digiceutical 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Digiceutical 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Digiceutical 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Digiceutical 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Digiceutical 麻豆原创 Size (2018-2029)
9.2 Latin America Digiceutical 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Digiceutical 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Digiceutical 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Digiceutical 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Digiceutical 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Digiceutical 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Digiceutical 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pear Therapeutics Inc
11.1.1 Pear Therapeutics Inc Company Detail
11.1.2 Pear Therapeutics Inc Business Overview
11.1.3 Pear Therapeutics Inc Digiceutical Introduction
11.1.4 Pear Therapeutics Inc Revenue in Digiceutical Business (2018-2023)
11.1.5 Pear Therapeutics Inc Recent Development
11.2 Akili Interactive Labs, Inc
11.2.1 Akili Interactive Labs, Inc Company Detail
11.2.2 Akili Interactive Labs, Inc Business Overview
11.2.3 Akili Interactive Labs, Inc Digiceutical Introduction
11.2.4 Akili Interactive Labs, Inc Revenue in Digiceutical Business (2018-2023)
11.2.5 Akili Interactive Labs, Inc Recent Development
11.3 Propeller Health
11.3.1 Propeller Health Company Detail
11.3.2 Propeller Health Business Overview
11.3.3 Propeller Health Digiceutical Introduction
11.3.4 Propeller Health Revenue in Digiceutical Business (2018-2023)
11.3.5 Propeller Health Recent Development
11.4 Welldoc
11.4.1 Welldoc Company Detail
11.4.2 Welldoc Business Overview
11.4.3 Welldoc Digiceutical Introduction
11.4.4 Welldoc Revenue in Digiceutical Business (2018-2023)
11.4.5 Welldoc Recent Development
11.5 Voluntis
11.5.1 Voluntis Company Detail
11.5.2 Voluntis Business Overview
11.5.3 Voluntis Digiceutical Introduction
11.5.4 Voluntis Revenue in Digiceutical Business (2018-2023)
11.5.5 Voluntis Recent Development
11.6 Chrono Therapeutics Inc.
11.6.1 Chrono Therapeutics Inc. Company Detail
11.6.2 Chrono Therapeutics Inc. Business Overview
11.6.3 Chrono Therapeutics Inc. Digiceutical Introduction
11.6.4 Chrono Therapeutics Inc. Revenue in Digiceutical Business (2018-2023)
11.6.5 Chrono Therapeutics Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Pear Therapeutics Inc
Akili Interactive Labs, Inc
Propeller Health
Welldoc
Voluntis
Chrono Therapeutics Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.